Synchrony of gene expression and the differentiation of myeloid leukemic cells: reversion from constitutive to inducible protein synthesis
- PMID: 6580168
- PMCID: PMC555166
- DOI: 10.1002/j.1460-2075.1983.tb01481.x
Synchrony of gene expression and the differentiation of myeloid leukemic cells: reversion from constitutive to inducible protein synthesis
Abstract
There are mutant myeloid leukemic cells that cannot be induced to differentiate in serum-free culture medium, or medium with calf serum by the macrophage and granulocyte differentiation-inducing protein (MGI-2) that induces differentiation in normal myeloid cells. These mutants can be induced to differentiate by MGI-2 in medium with mouse serum. The mechanism of this induction of differentiation has been analysed by using two-dimensional gel electrophoresis to study changes in the synthesis of cytoplasmic proteins. In calf serum, 46 of the protein changes that were induced by MGI-2 in normally differentiating cells were constitutive in the differentiation-defective mutant cells. Treatment with mouse serum reverted 13 of these proteins from the constitutive to the non-constitutive state. This reversion was associated with a gain of inducibility for various differentiation-associated properties, so that 23 proteins were induced by MGI-2 for the same type of change as in normal differentiation. A normal developmental program requires synchrony of gene expression. The existence of constitutive instead of inducible gene expression can produce asynchrony in this program and thus produce blocks in differentiation. The results indicate that it is possible to treat these mutant cells so as to induce the reversion of specific proteins from the constitutive to the non-constitutive state, and that this can then restore the synchrony required for induction of differentiation. It is suggested that this mechanism may also allow induction of differentiation in other types of differentiation-defective cells.
Similar articles
-
Control of in vivo differentiation of myeloid leukemic cells. IV. Inhibition of leukemia development by myeloid differentiation-inducing protein.Int J Cancer. 1984 Jan 15;33(1):147-54. doi: 10.1002/ijc.2910330122. Int J Cancer. 1984. PMID: 6582051
-
Target-cell specificity of hematopoietic regulatory proteins for different clones of myeloid leukemic cells: two regulators secreted by Krebs carcinoma cells.Int J Cancer. 1988 Apr 15;41(4):622-8. doi: 10.1002/ijc.2910410424. Int J Cancer. 1988. PMID: 3258591
-
Autoinduction of differentiation in myeloid leukemic cells: restoration of normal coupling between growth and differentiation in leukemic cells that constitutively produce their own growth-inducing protein.EMBO J. 1982;1(11):1343-6. doi: 10.1002/j.1460-2075.1982.tb01320.x. EMBO J. 1982. PMID: 6985353 Free PMC article.
-
[Differentiation inducing factor of leukemia cells and antineoplastic agents].Nihon Rinsho. 1982;40(8):1865-71. Nihon Rinsho. 1982. PMID: 6755002 Review. Japanese. No abstract available.
-
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.Blood. 1983 Oct;62(4):709-21. Blood. 1983. PMID: 6192859 Review.
Cited by
-
Hematopoietic growth and differentiation factors and the reversibility of malignancy: cell differentiation and by-passing of genetic defects in leukemia.Med Oncol Tumor Pharmacother. 1986;3(3-4):165-76. doi: 10.1007/BF02934993. Med Oncol Tumor Pharmacother. 1986. PMID: 3543530 Review.
-
DNA-binding protein that induces cell differentiation.EMBO J. 1983;2(12):2103-7. doi: 10.1002/j.1460-2075.1983.tb01709.x. EMBO J. 1983. PMID: 6583056 Free PMC article.
-
Cell differentiation and malignancy.Cell Biophys. 1986 Dec;9(1-2):225-42. doi: 10.1007/BF02797384. Cell Biophys. 1986. PMID: 2436796
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical